People
Gillian Russell has over 15 years of experience counseling pharmaceutical, medical device, and cosmetic clients on a wide range of regulatory, compliance, and enforcement issues, with a focus on regulatory strategies and initiatives for the labeling, promotion and advertising of FDA-regulated products. Gillian frequently serves as legal counsel on Medical/Legal/Regulatory (MLR) committees and medical/scientific review committees and is known for providing practical and actionable advice and solutions. Gillian routinely advises on the full spectrum of promotional and non-promotional communications, including new product launches, direct-to-consumer promotion, social media, influencer marketing, and payer communications.
Gillian graduated from the University of Virginia School of Law, where she served as Executive Editor for the Virginia Environmental Law Journal and as a Hardy Cross Dillard fellow for legal research and writing. Gillian earned her B.A. magna cum laude from Princeton University, where she was a four-year member of the swimming team.
J.D., University of Virginia
B.A., Princeton University, magna cum laude
District of Columbia
New Jersey
Pennsylvania
November 8, 2016
King & Spalding Promotes Eight Counsel in Three Offices
“Industry Update – New FDA Guidance on Social Media,” FX Conferences (September 2014).
“The New Drug Approval Process: New Drug Research and Development,” FDLI Introduction to Drug Law and Regulation, Washington, D.C. (April 2, 2014).
October 25, 2023
Beyond Reprints for Scientific Information on Unapproved Uses of Medical Products
August 10, 2023
FTC Revamps the “Guides Concerning the Use of Endorsements and Testimonials in Advertising”
June 30, 2023
FDA Finalizes Guidance on Presenting Quantitative Efficacy and Risk Information in DTC Promotion
November 8, 2016
King & Spalding Promotes Eight Counsel in Three Offices
“Industry Update – New FDA Guidance on Social Media,” FX Conferences (September 2014).
“The New Drug Approval Process: New Drug Research and Development,” FDLI Introduction to Drug Law and Regulation, Washington, D.C. (April 2, 2014).
October 25, 2023
Beyond Reprints for Scientific Information on Unapproved Uses of Medical Products
August 10, 2023
FTC Revamps the “Guides Concerning the Use of Endorsements and Testimonials in Advertising”
June 30, 2023
FDA Finalizes Guidance on Presenting Quantitative Efficacy and Risk Information in DTC Promotion
November 8, 2016
King & Spalding Promotes Eight Counsel in Three Offices
J.D., University of Virginia
B.A., Princeton University, magna cum laude
District of Columbia
New Jersey
Pennsylvania